Certain Biotech Investors Get an Early Look at Results. Is That Fair?

Certain Biotech Investors Get an Early Look at Results. Is That Fair?·The Wall Street Journal
In this article:

Private investments in public equities, or PIPEs, are all the rage in biotech, but some investors resent the sharing of nonpublic information.

Advertisement